Glomerular platelet-activating factor levels and origin in experimental glomerulonephritis. The content of platelet activating factor (PAF) in glomeruli isolated from rats with nephrotoxic serum glomerulonephritis (NSGN) was quantified at various stages of the disease and the role of complement, platelets and neutrophils in mediating changes in glomerular PAF levels was evaluated. PAF content was assessed following extraction, isolation and quantification of this alkyl ether lipid using a bioassay based on [3H]-serotonin release from labelled rabbit platelets. Following induction of NSGN using proteinuric doses of rabbit immune serum raised against rat glomerular basement membrane, enhanced glomerular PAF levels were observed at 3 hours, 24 hours and on day 15 following induction of the disease. In complement depleted rats and at three hours following induction of NSGN, glomerular PAF levels were significantly lower than in complement replete controls studied in parallel. At the same time point of the disease, platelet depleted rats with NSGN demonstrated significantly lower glomerular PAF levels than parallel controls, whereas in neutrophil depleted rats glomerular PAF levels were no different than controls. These observations indicate that in infiltrative and complement dependent forms of glomerular immune injury, glomerular PAF levels are increased via a complement mediated mechanism. Infiltrating platelets, but not neutrophils, partially account for the enhanced glomerular PAF levels. The observations are of potential importance in the pathophysiology of glomerulonephritis.
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The renal glomerulus and its various cell types have been demonstrated to synthesize compounds with autacoid and proinflammatory effects [1, 2] . The spectrum of proinflammatory compounds of glomerular origin has recently expanded to include the alkyl ether glycerophospholipids, including 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine, which is structurally identical with platelet activating factor (PAF). This compound can induce platelet and neutrophil aggregation and chemotaxis, vasodilation and increased vascular permeability and stimulation of eicosanoid production [3] . We have demonstrated that PAF can be both synthesized and degraded in isolated glomeruli [4] and in mesangial cells [5] , the latter being also capable of de novo synthesis of PAF precursors [6] . Recent observations indicate that PAF receptor antagonism ameliorates glomerular inflammation in rabbit nephrotoxic serum nephritis [71 as well as the glomerular inflammatory injury Received for publication December 21, 1987 and in revised form August 18, 1989 Accepted for publication August 23, 1989 © 1990 by the International Society of Nephrology induced by in situ formation of immune complexes in the rat kidney with experimental passive reverse Arthus reaction [8] .
The present study was undertaken to assess the levels and cellular sources of glomerular PAF in glomeruli isolated from rats with nephrotoxic serum glomerulonephritis (NSGN), an infiltrative and complement dependent model of glomerular immune injury. The role of complement system in mediating changes in glomerular PAF levels was also assessed.
Methods
Induction of nephrotoxic serum glomerulonephritis (NSGN) NSGN was induced in male Sprague-Dawley rats, weighing 250 to 300 g, by a single intravenous injection of proteinuric doses of rabbit immune serum raised against particulate rat glomerular basement membrane (GBM) as previously described [9] . The immunoglobulin concentration of the immune serum employed was determined by the immunodiffusion method of Mancini, Carbonassa and Hermans [10] using goat anti-rabbit IgG (Cappel Laboratories, Cochranville, Pennsylvania, USA) and rabbit IgG (Sigma Chemical Company, St. Louis, Missouri, USA). In all experiments, a single dose of immunoglobulin was given (100 to 110 p.g/g of rat body wt), capable of inducing proteinuria in the range of 150 to 250 mg of protein in 18-to 20 -hour urine collection.
The following groups of animals were studied: a) rats with NSGN studied at 3 hours, 24 hours and 15 days (N 4 to 6 for each time point) following administration of anti-GBM immunoglobulin. Controls for each time point received identical amounts of rabbit non-immune serum.
b) A group with NSGN underwent complement depletion (N = 4) using cobra venom factor (CVF) (Sigma Chemical Co.)
purified by ion exchange and gel filtration chromatography [11] and given intraperitoneally within a 24 hour interval and in three divided doses (10 U/lOO g body wt) prior to administration of anti-GBM immune serum. Complement depletion was documented in serum samples by a hemolysis inhibition assay (CH5O) using antibody-sensitized sheep erythrocytes. In this complement depleted group, studies were performed at three hours following administration of the anti-GBM serum and results were compared to the complement replete group of rats with NSGN studied at three hours. Controls received CVF alone. c) A group with NSGN underwent platelet depletion (N 5) prior to administration of anti-GBM immunoglobulin by a single Glomeruli were incubated with 100 nCi of 3H-PAF and incubated for 20 mm at ambient temperature, Lipids were extracted and a portion was analyzed by TLC. Product formation was expressed as pg lyso-PAF per mg glomerular protein, calculated on the basis of 3H-PAF specific activity.
intraperitoneal injection of rabbit anti-rat platelet immune serum (source: Dr. K. Johnson, Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA). Platelet depletion was documented by assessing the absolute platelet counts in peripheral blood samples using an automated hematology analyzer; studies in this group were performed at three hours following induction of NSGN and were confined to animals in which the peripheral blood platelet count was less that 10,000/mm3. Controls received non-immune rabbit serum.
d) A group with NSGN underwent neutrophil depletion (N = 4) by a single intrapentoneal injection of rabbit anti-rat polymorphonuclear leukocyte (PMN) immune serum (Accurate Chemical Co., Westbury, Massachusetts, USA) given 18 to 20 hours prior to induction of NSGN. PMN depletion was documented by assessing absolute PMN counts in peripheral blood using an automated hematology analyzer. Studies were performed at three hours following induction of NSGN and were confined to animals in which peripheral PMN counts of less than 200 PMNs/mm3 were attained. Glomerular lesions were assessed by light and immunofluorescence microscopy. Gbmerular neutrophil infiltration was assessed by counting the number of neutrophils in 20 glomeruli in renal cortical sections obtained by sacrifice and stained by Eosin-Hematoxylin. Gbmerular complement (C3) deposition was assessed by staining for rat C3 using FTIC-conjugated goat anti-rat C3 immunoglobulin (Cappel).
Biochemical studies
These studies assessed the content of PAF in glomeruli isolated from the various groups of animals described above. In a first step, we performed a number of experiments in order to assess the metabolism of PAF by glomeruli isolated from rats with NSGN at 24 hours following injection of the anti-GBM immune serum (N = 4) and from control rats (receiving nonimmune rabbit serum) (N = 4). Glomerular incubations were performed in RPMI medium-l640 (Gibco Laboratories, Grand Island, New York, USA) with 100 nCi of l-0-[3H]-octadecyl-ular isolation, a procedure which involves a 30 to 45 minute time period. Therefore, we performed two types of measurements: At the various time points of study (3 hours, 24 hours, day 15), glomerular lipids were extracted immediately following glomerular isolation and according to the procedure described by Bligh and Dyer [12] . Briefly, glomeruli isolated by differential sieving [9] were suspended in 2 ml of RPMI medium 1640 in polypropylene tubes at ambient temperature (23°C) and "spiked" with approximately 3000 cpm of [3H] PAF standard in order to calculate recoveries of this compound. Two ml of potassium chloride 2 M/EDTA 0.5 M were subsequently added followed by 5 ml of acidified (2% acetic acid) methanol.
Supernatants were further extracted three times with 4 ml of chloroform and the chloroform-rich phases were pooled and dried under nitrogen. Glomerular lipid extracts were subsequently dissolved in 300 d of chboroform:pyridine (3:1) and were acetylated in the presence of acetic anhydride, 30 .d, and of 4-N-dimethyl amino-pyridine, 2 mg, for 18 hours at ambient temperature [131. Acetylated lipid extracts were subsequently loaded on silica preparatory columns (SepPak, Waters Associates) which were pre-washed with chboroform:methanol (3:1). Columns were sequentially eluted with 5 ml of chloroform: methanol (1:1), 10 ml of methanol and 5 ml of methanol:water (3:1). PAF was recovered in the last eluate which was dried under vacuum and reconstituted in 300 s1 of sodium chloride 0.15 M/bovine serum albumin (BSA) 0.35% to be used for quantification by the [3H] serotonin release assay. As chemical acetylation may completely acetylate all lyso-PAF to PAF, including the amount of lyso-PAF which had been produced in vivo and prior to initiation of the glomerular isolation procedure, this approach may not reflect PAF levels biologically generated in vivo. Moreover, lyso-PAF cannot be regarded as a sole index of PAF generation as it may also originate from glomerular alkyl acyl phosphatidyicholine following activation of phospholipase A2. Therefore, glomerular PAF content in the various experimental groups was also determined without prior acetylation of lipid extracts. In these measurements glomerular isolations and lipid extractions were performed at 4°C, a temperature at which the activity of glomerular acetyl hydrolase has been shown to be significantly inhibited [5J.
To quantify PAF content in glomerular lipid extracts, the [3H] serotonin release assay was used and employed fresh rabbit platelets labelled with [3H] serotonin and prepared from rabbit platelet-rich plasma as previously described [14] . Labelled platelets were suspended in tris-Tyrode's buffer containing BSA 0.25% and consisting of KC1 2.6 X iO M, NaCl 1.37 x 101 M, tris(hydroxy-methyl-aminomethane) 1 x 10 M and glucose 0.1%, pH 7.4. The suspension contained 1.25 x 106 platelets per d. To perform the assay, in 400 .d of trisTyrode's/BSA supplemented with CaCl2 6 H20 1.3 x l0 M and MgCl2 6 H20 1 x l0-M and containing indomethacin 1 x i0 M, creatinine phosphate 312.5 /Lg/ml and creatinine phosphokinase 152.5 tg/ml, a defined volume (50 d) of glomeruli-derived PAF extract was added followed by 100 pi of a [3H] serotoninlabelled platelet suspension. The mixture was allowed to incubate at 37° for three minutes and the reaction was stopped by 50 d formaldehyde 0.5 M, followed by centrifugation at 12000 g for three minutes. Duplicate 100 jd aliquots of the supernate were counted in a liquid scintillation counter (LKB WalIac, 1217 Rackbeta, Bromma, Sweden). Results were obtained on the basis of a standard curve using PAF standard (range 0.1 ng to 1 ng). To construct the curve, the in of (dpm sample/dpm 100% lysis-dpm sample) was plotted against known amounts of PAF standard. One hundred percent platelet lysis was obtained by the addition of 2.5% Triton X. The (dpm sample) and (dpm 100% lysis) values were corrected for background [3H] serotonm radioactivity "noise" determined in samples containing vehicle (tris-Tyrode's) only. Glomerular PAF levels were expressed as mean SE values. Statistical comparisons employed the Student's I-test for unpaired observations. As the use of bioassay may be associated with considerable interassay variation, PAF content in a number of glomeruiar extracts from different experimental groups were determined in the same assay. For samples assayed in different bioassays the interassay coefficient of variation was determined. For animals receiving nonimmune serum and studied in parallel with either the various time groups or the complement depleted groups or the neutrophile/platelet depleted groups, the glomerular PAF content averaged 3.0 0.5, cantly lower (P < 0.001) compared to values obtained at 3 hours, 24 hours and on day 15. PAF content values obtained using chemical acetylation of glomerular lipid extracts were higher (47.2 8.6 at 3 hr; 60 12 at 24 hr and 73 8 on day 15) compared to those obtained in non-acetylated glomerular lipid extracts. Figure 2 demonstrates the effects of complement depletion on glomerular PAF levels in NSGN. In the complement depleted group of rats studied at 3 hours (Group III), glomerular PAF levels were significantly lower compared to the complement replete three-hour group with NSGN studied in parallel (Group II; 9.3 1.3, N = 4, compared to 32.9 5.4, N = 6 pmol/mg protein, P < 0.001). In the complement depleted group (Group III), glomerular PAF levels remained higher compared to controls receiving non-immune serum and studied in parallel (Group I; 9.3 1.3, N = 4, compared to 3.8 1.0 pmol/mg protein, P < 0.001). Control rats receiving CVF alone (Group IV) also had higher glomerular PAF levels compared to those receiving non-immune rabbit serum (7.6 0.4, N = 3, compared to 3.8 1.0 pmol/mg glomerular protein, P < 0.001).
In Figure 3 , the effects of platelet depletion and PMN depletion on glomerular PAF levels are shown. In the p4telet depleted group of rats with NSGN studied at 3 hours (Group IV), glomerular PAF levels were 13.9 1.8 pmollmg glomerular protein (N 5), and this value was significantly lower (P < 0.01) compared to the platelet replete group studied at 3 hours (Group II) (25.1 2.7 pmol/mg glomerular protein, N = 4). In the neutrophile depleted group (Group III), glomerular PMN infiltration was abolished (0 to 1 PMN/glomerulus). In this group, glomerular PAF levels were not significantly different from the neutrophil replete group studied at 3 hours following induction of NSGN (Group II; 18.9 2.5, N = 4, compared to 25 .1 2.7 pmollmg glomerular protein).
Discussion
Investigative work on the synthesis and role of alkyl ether glycerophospholipids has recently involved the mammalian kidney [15, 16] . We have confirmed previous observations [17] that the rat glomerulus and mesangial cells can synthesize 1-0-alkyl-2-acetyl-sn-glycero-phosphocholine (PAF) via an acetyl transferase as well as via a CDP choline phosphotransferase utilizing 1-0-alkyl-2-lyso-glycerophosphocholine or 1-0-alkyl-2-acetyl-glycerol as substrates [4, 5] . Moreover, we have demonstrated a significant degree of PAF enzymatic degradation in glomerular tissue and in mesangial cells to its biologically-inactive lyso-PAF compound [4] . Recent observations indicate that in glomerular immune injury induced by anti-GBM antibody [7] or by in situ glomerular immune complex formation [8] , PAF apparently mediates pathophysiologic perturbations and changes in glomerular permeability. It was also demonstrated that cultured glomerular mesangial cells release PAF and eicosanoids in response to IgG binding via the fc receptor [18] . In the isolated perfused kidney platelet activating factor (s-PAF) increases glomerular permeability without an effect on electrostatic barriers of the capillary wall [19] . In an attempt to quantify glomerular PAF levels in immunologically injured glomeruli, this study employed a well established bioassay, based on the ability of this alkyl-ether lipid to induce [3H] serotonin release from freshly harvested and [3H] serotoninlabelled rabbit platelets. Our experiments on glomerular metabolism of PAF indicate substantial acetyl hydrolase activity (Table 1 ). In view of the extent of PAF degradation observed in glomerular preparations, we initially performed chemical acetylation of glomeruli-derived lipid extracts in order to convert all lyso-PAF generated during glomerular isolation to bioassayable PAF. The results indicated enhanced glomerular PAF content at 3 hours, 24 hours and on day 15 following administration of a single proteinuric dose of anti-GBM immune serum. However, since amounts of PAF obtained following chemical acetylation of lyso-PAF may not reflect biologically synthesized PAF in vivo and because lyso-PAF is not necessarily an index of tissue PAF generation as it may also originate from alkyl acyl glycerophosphocholine following phospholipase A2 activation, we performed measurements of bioassayable PAF lipid extracts obtained following glomerular isolation at 4°C to minimize the activity of acetyl hydrolase. As demonstrated in Figure 1 , enhanced glomerular PAF content was found in immunologically injured glomeruli at the three time points of study. Several sources of PAF can be implicated in this model of glomerular injury. Blood-born platelets and neutrophils which are invariable present in glomeruli of rats with NSGN can account for the enhanced glomerular PAF content, since both cell types can synthesize PAF in response to various stimuli [20] . The platelet and neutrophil depletion studies indicate that platelets, but not neutrophils, partially account for the increased glomerular PAF levels observed at 3 hours following induction of NSGN (Fig.  3) . The complement depletion studies indicate that the complement system also mediates the increments in glomerular PAF levels (Fig. 2) . In complement-dependent forms of glomerular injury, such as NSGN, activation of complement components in glomeruli could mediate PAF synthesis by glomerular cells. Indirect evidence that systemic activation of the complement system can enhance glomerular PAF levels can be derived from the observations that in rats which received intraperitoneal injections of purified CVF (cobra C3b), glomerular PAF levels were increased compared to the control group of rats which received non-immune serum (Fig. 2) . Moreover, in a preliminary study, we have demonstrated that anaphylatoxin C3a can stimulate the activity of acetyl CoA: 1-0-alkyl-2-lyso-glycerophosphocholine acetyltransferase which acetylates the precursor lyso-PAF to PAF [21] . Endogenous glomerular cells, including endothelial, mesangial and the recently identified Ia-bearing resident macrophages, the number of which increases in neph-rotoxic serum nephritis [22] , could also be potential sources of enhanced PAP synthesis in immunologically injured glomeruli. Vascular endothelial cells in culture also synthesize PAF 123] as do glomerular mesangial cells in response to defined immunologic stimuli [18] .
Whether reflecting an increase in PAF synthesis by glomerular cells or an increase in the number of cells (that is, platelets) capable of synthesizing PAF in the immunologically injured glomerulus, increments in PAF levels can be of potential pathophysiologic significance in glomerular immune injury. In this regard, of relevance are the recent observations that administration of exogenous PAF increases the permeability of the glomerular basement membrane and reduces GFR by affecting primarily the ultrafiltration coefficient [24] . This determinant of GFR can be partially modulated by the contractile state of mesangial cells which exhibit contractile responses when exposed to PAF [25] . Moreover, PAF may induce loss of anionic charges in glomerular basement membrane [26] , an effect which could mediate proteinuria in glomerular immune injury. Finally, evidence for a regulatory relationship between glomerular PAF and TxA2 synthesis has recently been demonstrated in NSGN. Specifically, PAP receptor blockade ameliorates enhanced glomerular TxA2 synthesis and proteinuria, and has a beneficial effect on glomerular histopathology [27] .
